Advanced NMR announced last week that it has canceled its proposedmerger with Advanced Mammography Systems, the breast MRI developerof which it owns a majority interest.Advanced NMR, of Wilmington, MA, had originally planned to bringAMS under its wing
Advanced NMR announced last week that it has canceled its proposedmerger with Advanced Mammography Systems, the breast MRI developerof which it owns a majority interest.
Advanced NMR, of Wilmington, MA, had originally planned to bringAMS under its wing because of capitalization issues at the subsidiary.AMS recently completed a private placement of $3 million worthof convertible debentures, however, enabling the unit to remainindependent. Proceeds from the debenture issue will be used toaccelerate the completion of product development for AdvancedMammography Systems' Aurora dedicated breast MRI scanner and tofund a global product launch of the machine.
The merger cancellation renders moot a class action shareholderlawsuit filed against Advanced NMR earlier this year seeking tostop the merger (SCAN 2/28/96). Advanced NMR will continue toown 61% of AMS.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.